Pyxis Oncology (PYXS) Current Leases (2020 - 2025)

Pyxis Oncology (PYXS) has 5 years of Current Leases data on file, last reported at $1.7 million in Q4 2025.

• On a quarterly basis, Current Leases rose 16.69% year-over-year to $1.7 million in Q4 2025; TTM through Dec 2025 was $1.7 million, a 16.69% increase from a year earlier, with the FY2025 full-year figure at $1.7 million, up 16.69% from the prior year.
• Current Leases for Q4 2025 stood at $1.7 million, up from $1.6 million in the prior quarter.
• Over the last five years, Current Leases for PYXS reached as high as $1.7 million in Q4 2025 and fell as low as $165000.0 in Q4 2021.
• Historically, Current Leases has averaged $1.1 million across 4 years, with a median of $1.2 million in 2023.
• Across the five-year window, Current Leases sank 73.17% in 2021 and surged 47.84% in 2025, its largest moves.
• Year by year, Current Leases stood at $165000.0 in 2021, then jumped by 646.67% to $1.2 million in 2023, then gained by 17.69% to $1.4 million in 2024, then advanced by 16.69% to $1.7 million in 2025.
• Per Business Quant data, the three most recent Current Leases figures were $1.7 million in Q4 2025, $1.6 million in Q3 2025, and $1.6 million in Q2 2025.